Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03995745 · ClinicalTrials.gov registry record · NA

Medication Adherence and Outcomes Among Patients in United States With HIV

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT03995745: Completed NA study, sponsored by University of Pennsylvania.

NCT03995745 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03995745, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

With support from the NIH, this pilot study will assess the feasibility of using wireless devices and financial incentives to motivate medication adherence among HIV-positive adults in the U.S., focusing on those with non-suppressed viral loads. While daily lotteries using wireless devices may have great potential for improving adherence to ART regimens, substantial questions exist as to whether it is: 1) possible to achieve high rates of uptake for a pilot offering wireless devices to high-risk populations; 2) achieve high rates of sustained engagement.

Primary Outcome

viral load less than 400

Interventions

  • BEHAVIORAL Medication adherence and financial incentives

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2019-05-16
Est. Completion 2020-10-13
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT03995745 record still lists

NCT03995745 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Medication adherence and financial incentives is the first listed.

NCT03995745 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03995745 about?

NCT03995745 is a clinical study titled "Medication Adherence and Outcomes Among Patients in United States With HIV". With support from the NIH, this pilot study will assess the feasibility of using wireless devices and financial incentives to motivate medication adherence among HIV-positive adults in the U.S., focusing on those with non-suppressed viral loads. While daily lotteries using wireless devices may have...

What is the current status of trial NCT03995745?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-05-16. Estimated completion is 2020-10-13.

What interventions are being tested in trial NCT03995745?

The interventions under investigation include: Medication adherence and financial incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT03995745?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03995745's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03995745, the US trial registry maintained by the National Library of Medicine. NCT03995745 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.